RHB-104

DRUG2 trials

Sponsors

RedHill Biopharma Limited

Conditions

Crohn's DiseaseRelapsing Remitting Multiple Sclerosis

Phase 2

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

CompletedNCT01717664

RedHill Biopharma LimitedRelapsing Remitting Multiple Sclerosis

Start: 2013-06-30End: 2016-07-31Updated: 2016-07-28

Phase 3

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

CompletedNCT01951326

RedHill Biopharma LimitedCrohn's Disease

Start: 2013-09-30End: 2019-08-31Updated: 2020-12-08

Related Papers

Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn’s Disease

Antibiotics2024-07-254 citations